Amanote Research
Register
Sign In
Tubeimoside I Sensitizes Cisplatin in Cisplatin-Resistant Human Ovarian Cancer Cells (A2780/Ddp) Through Down-Regulation of ERK and Up-Regulation of P38 Signaling Pathways
Molecular Medicine Reports
- Greece
doi 10.3892/mmr.2011.513
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Date
June 17, 2011
Authors
Zhu Yang
Publisher
Spandidos Publications
Related search
Heparin Antagonizes Cisplatin Resistance of A2780 Ovarian Cancer Cells by Affecting the WNT Signaling Pathway
Oncotarget
Oncology
Ailanthone Inhibits Cell Growth and Migration of Cisplatin Resistant Bladder Cancer Cells Through Down-Regulation of Nrf2, YAP, and C-Myc Expression.
Phytomedicine
Molecular Medicine
Pharmacology
Complementary
Alternative Medicine
Pharmaceutical Science
Drug Discovery
Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1
OncoTargets and Therapy
Oncology
Pharmacology
Transcriptional Up-Regulation of SOD1 by CEBPD: A Potential Target for Cisplatin Resistant Human Urothelial Carcinoma Cells
Biochemical Pharmacology
Biochemistry
Pharmacology
MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin-Induced Apoptosis
Cancer Studies and Molecular Medicine - Open Journal
Resensitization of Cisplatin Resistance Ovarian Cancer Cells to Cisplatin Through Pretreatment With Low‐dose Fraction Radiation
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Effects of VBMDMP on the Reversal of Cisplatin Resistance in Human Lung Cancer A549/DDP Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Etlingera Elatior Extract Promotes Cell Death in B16 Melanoma Cells via Down-Regulation of ERK and Akt Signaling Pathways
BMC Complementary and Alternative Medicine
Medicine
Alternative Medicine
Complementary
